Yanguanjia TM Series Breath Analyzer

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

A high-precision nitric oxide (NO) measurement device designed for detecting NO and non-oxygen carbon dioxide in exhaled gas. The eNoglow series includes models LN1000, LN2000, LN3000, and LN4000, with a measurement range of 0-5000ppb and a resolution of 0.01ppb. It is a Class II medical device registered with China's NMPA and designed to meet the high standards required in clinical settings such as pediatrics, cardiology, and intensive care units.

Diagnostic instrument for analyzing exhaled breath gases in clinical and research settings. Utilized for hydrogen breath testing and other respiratory diagnostic procedures.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Carbon-13 breath test analyzer for non-invasive diagnosis of gastrointestinal disorders including H. pylori infection, small intestinal bacterial overgrowth, and lactose malabsorption. The device measures exhaled carbon-13 levels to assess metabolic function and intestinal health with rapid turnaround times.

A compact breath analysis device that detects volatile sulfur compounds (VSCs) in human exhalation to assess periodontal disease risk. The device measures VSC emissions and pH levels, providing quantitative data for early detection of oral health conditions.

A diagnostic analyzer for conducting carbon-14 urea breath tests to detect gastric bacterial infections. The device measures isotopic composition in breath samples for clinical diagnosis.

A diagnostic device for measuring nitric oxide (NO) levels in exhaled breath, available in models Reslink R100 and Reslink R200. It has a measurement range of 1-3500ppb and is a Class II medical device certified by China's NMPA. The device is used for assisting in the diagnosis and assessment of conditions such as asthma and chronic obstructive pulmonary disease, as well as for monitoring disease progression.

A wearable device that performs laboratory-level analysis of biomarkers in breath samples in near-real-time. Based on headspace gas chromatography technology, it enables on-site measurement of metabolic markers including fat combustion indicators. Developed through 15+ years of research at ETH Zurich.

A 13/12 CO2 breath gas analyzer that measures stable isotope ratios in exhaled breath for diagnostic testing. It provides an efficient alternative to costly mass spectrometric methods for breath test analysis.

An analytical device for all breath tests using 13C-labeled tracer substances. This analyzer is capable of measuring various diagnostic breath tests including H. pylori detection, liver function assessment, gastric emptying, and pancreatic function evaluation.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.